CA5A

Across TCGA pan-cancer cohorts, CA5A Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated CA5A data layer compared with 22 for mass-spec protein.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher CA5A Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated CA5A expression acts as an unfavorable survival marker.

BLCA, UCEC, and PRAD are the cancer types where CA5A Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Median	All	0.067	0.628	<.001	39	view →
UCEC	OS	Median	IV	0.066	0.755	<.001	12	view →
PRAD	DFS	Median	All	0.068	0.774	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

CA5A–BLCA (DFS)

Open the BLCA breakdown →